Pharmacogenomics for Prader-Willi syndrome : caregiver interest and planned utilization
Aim: The study aim was to determine caregiver interest and planned utilization of pharmacogenomic (PGx) results for their child with Prader-Willi syndrome. Methods: Caregivers consented to PGx testing for their child and completed a survey before receiving results. Results: Of all caregivers (n = 48), 93.8% were highly interested in their child's upcoming PGx results. Most (97.9%) planned to share results with their child's medical providers. However, only 47.9% of caregivers were confident providers would utilize the PGx results. Conclusion: Caregivers are interested in utilizing PGx but are uncertain providers will use these results in their child's care. More information about provider comfort with PGx utilization is needed to understand how PGx education would benefit providers and ultimately patients with PGx results.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
Pharmacogenomics - 25(2024), 4 vom: 27. März, Seite 207-216 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bar-Peled, Yael [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Caregiver |
|---|
| Anmerkungen: |
Date Completed 27.03.2024 Date Revised 27.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2217/pgs-2023-0189 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369959329 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369959329 | ||
| 003 | DE-627 | ||
| 005 | 20240328000241.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240320s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/pgs-2023-0189 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1351.xml |
| 035 | |a (DE-627)NLM369959329 | ||
| 035 | |a (NLM)38506331 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bar-Peled, Yael |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmacogenomics for Prader-Willi syndrome |b caregiver interest and planned utilization |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.03.2024 | ||
| 500 | |a Date Revised 27.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Aim: The study aim was to determine caregiver interest and planned utilization of pharmacogenomic (PGx) results for their child with Prader-Willi syndrome. Methods: Caregivers consented to PGx testing for their child and completed a survey before receiving results. Results: Of all caregivers (n = 48), 93.8% were highly interested in their child's upcoming PGx results. Most (97.9%) planned to share results with their child's medical providers. However, only 47.9% of caregivers were confident providers would utilize the PGx results. Conclusion: Caregivers are interested in utilizing PGx but are uncertain providers will use these results in their child's care. More information about provider comfort with PGx utilization is needed to understand how PGx education would benefit providers and ultimately patients with PGx results | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Prader-Willi syndrome | |
| 650 | 4 | |a caregiver | |
| 650 | 4 | |a personalized medicine | |
| 650 | 4 | |a perspectives | |
| 650 | 4 | |a pharmacogenomic testing | |
| 650 | 4 | |a pharmacogenomics | |
| 700 | 1 | |a Denton, Jessica J |e verfasserin |4 aut | |
| 700 | 1 | |a Richards, Jaimie L |e verfasserin |4 aut | |
| 700 | 1 | |a Brown, Donna |e verfasserin |4 aut | |
| 700 | 1 | |a Worthey, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Strong, Theresa V |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacogenomics |d 2000 |g 25(2024), 4 vom: 27. März, Seite 207-216 |w (DE-627)NLM111671396 |x 1744-8042 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2024 |g number:4 |g day:27 |g month:03 |g pages:207-216 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2217/pgs-2023-0189 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2024 |e 4 |b 27 |c 03 |h 207-216 | ||